<table>
  <tr>
    <td colspan="2"><b>Pre-Treatment Phase</b></td>
    <td colspan="8"><b>Treatment Phase<sup>1</sup></b></td>
    <td colspan="2"><b>Post-Treatment Phase</b></td>
  </tr>
  <tr>
    <td><b>Cycle Number</b></td>
    <td><b>Screening</b></td>
    <td colspan="4"><b>Cycle 1</b></td>
    <td colspan="2"><b>Cycle 2, 4, 6 etc.</b></td>
    <td colspan="2"><b>Cycle 3, 5, 7 etc.</b></td>
    <td><b>EOT</b></td>
    <td><b>1M FUP</b></td>
  </tr>
  <tr>
    <td>Day within Cycle Visit Window (± days)</td>
    <td>D-14 to D-1</td>
    <td>D1</td>
    <td>D8 (±2)</td>
    <td>D15 (±2)</td>
    <td>D22 (±2)</td>
    <td>D1</td>
    <td>D15 (±2)</td>
    <td>D1</td>
    <td>D15 (±2)</td>
    <td>≤ 10 d from the decision of trial treatment withdrawal</td>
    <td>1 month after last dose of trial treatment (28+7d)</td>
  </tr>
  <tr>
    <td>Informed Consent</td>
    <td>X</td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Baseline Characteristics/Eligibility<sup>2</sup></td>
    <td>X</td>
    <td>X</td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Safety Assessments</td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Medication Survey</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
  </tr>
  <tr>
    <td>(S)AE Survey and Reporting</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
  </tr>
  <tr>
    <td>DLT Evaluation (dose-escalation only)<sup>3</sup></td>
    <td></td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>C2/D1</td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Vital Signs and Body Weight</td>
    <td>X</td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
  </tr>
  <tr>
    <td>ECOG PS</td>
    <td>X</td>
    <td>X</td>
    <td></td>
    <td></td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td>X</td>
  </tr>
  <tr>
    <td>Physical Examination</td>
    <td>X</td>
    <td>X</td>
    <td></td>
    <td></td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td>X</td>
  </tr>
  <tr>
    <td>Dermatological Examination</td>
    <td>X</td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
  </tr>
  <tr>
    <td>ECG<sup>4</sup></td>
    <td>X</td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td>X</td>
    <td></td>
  </tr>
  <tr>
    <td>Safety blood samples<sup>5</sup></td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
  </tr>
  <tr>
    <td>Urinalysis<sup>5</sup></td>
    <td>X</td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td>X</td>
  </tr>
  <tr>
    <td>Pregnancy Test</td>
    <td>X</td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td>X</td>
    <td></td>
  </tr>
  <tr>
    <td>Disease Assessments</td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>(Archival) Tumor Biopsy Collection<sup>6,7</sup></td>
    <td>X</td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Tumor Marker Evaluation<sup>8</sup></td>
    <td>X</td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td>End of C</td>
    <td></td>
    <td></td>
    <td>X</td>
    <td>X</td>
  </tr>
  <tr>
    <td>Disease Status Evaluation by CT/ MRB<sup>9,10</sup></td>
    <td>X</td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td>End of C</td>
    <td></td>
    <td></td>
    <td>X</td>
    <td>X</td>
  </tr>
  <tr>
    <td>*Additional Assessments</td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>*PK Samples (dose-escalation only)<sup>11</sup></td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td>X</td>
  </tr>
  <tr>
    <td>*ADA Sample</td>
    <td></td>
    <td>X</td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td>X</td>
  </tr>
  <tr>
    <td>*Biomarker Blood and Urine Sample<sup>12</sup></td>
    <td>X</td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td>End of C2</td>
    <td></td>
    <td></td>
    <td>X</td>
    <td></td>
  </tr>
  <tr>
    <td>Trial Treatment</td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Skin Toxicity Prophylaxis and TX<sup>13</sup></td>
    <td></td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
  </tr>
  <tr>
    <td>Infusion Reaction Prophylaxis<sup>14</sup></td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Sym004 Infusion</td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Gastrointestinal Toxicity Prophylaxis<sup>15</sup></td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>FOLFIRI Infusion</td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td></td>
    <td></td>
  </tr>
  <tr>
    <td>Post-Infusion Monitoring</td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td></td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td>X</td>
    <td></td>
    <td></td>
  </tr>
</table>